Neurodegenerative diseases

With an increase of the average age of the population, prevention and treatment of neurodegenerative diseases is starting to play a very important role in the health care of developed countries.

Our strategic planning of therapeutic areas for development of new and generic drugs, as well as cellular products is based on the in-depth analysis of the patient population needs in the Russian Federation for various medical products and treatments. Currently, we are pursuing research and development of therapies for the following diseases and pathological conditions.

Among the neurodegenerative disorders there are severe medical conditions like multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and others.

At this point there is no common point of view on the causes and treatments of these diseases, and current therapy is not sufficiently effective and often has seriuos side effects. Above all, the existing therapies can only slow the progression of these diseases at best, but would not cure them. Therefore, there is a tremendous need for development of effective and safe therapeutics with novel mechanisms of action.

With an increase of the average age of the population, prevention and treatment of neurodegenerative diseases is starting to play a very important role in the health care of developed countries.